.webp)
PHARMACEUTICAL ETP CASE STUDY
Achieving 90% COD Reduction in Pharmaceutical ETP UASBR System
Industry: Oral Cephalosporin APIs (Cefixime, Cefdinir, Cefaclor, Cefuroxime Axetil, Cefpodoxime Proxetil, Cefditoren Pivoxil, Cefprozil)
Plant Capacity: 30 KLD ETP | Core Tech: UASBR
85–90%
COD Reduction (7,187 → 874 mg/L)
0.18
Optimal VFA/Alkalinity Ratio
25 Days
Full System Commissioning
1. Background & Technical Challenge
Plant Overview
A leading Indian manufacturer and global exporter of high-purity Oral Cephalosporin Active Pharmaceutical Ingredients (APIs) operates a 30 KLD wastewater treatment facility under strict cGMP conditions.
The facility’s Effluent Treatment Plant (ETP) relies on a combined anaerobic and aerobic biological process to treat highly complex chemical wastewater before final discharge or reuse.
The Technical Challenge & Risk
High Inlet COD: Raw levels ranging between 7,000 mg/L to 8,000 mg/L.
Regulatory Risk: Environmental standards required sharp organic load removal to avoid plant shutdown.
Commissioning Delays: Traditional seed sludge (cow dung) causes slow startup, bio-system collapse, VFA buildup, and costly downtime.
2. Effluent Process Flow Diagram (PFD)
The integrated treatment process routes raw effluent through biological and tertiary filtration units:
Flow Pathway: Raw Effluent → Collection Tank → Equalization Tank → Buffer Tank → UASBR → Primary Settling Tank → Aeration Tank → Secondary Settling Tank → ACF/PSF → UF → Outlet
3. Specialized Solution: BactaServe Anaerobic
To accelerate UASBR stabilization and prevent volatile acid accumulation, Amalgam Biotech deployed BactaServe Anaerobic, a specialized bacterial consortium engineered specifically for high-strength industrial effluent.
Biological Mechanisms of BactaServe Anaerobic
1. Hydrolysis
Breaks API polymers into soluble monomers.
2. Acidogenesis
Converts monomers into VFAs and alcohols.
3. Acetogenesis
Transforms VFAs into acetic acid, CO₂, and H₂.
4. Methanogenesis
Converts acetic acid & H₂ into biogas (CH₄ & CO₂).
Dosing Protocol (30 KLD Capacity)
Day Sequence | Daily Dosage (kg/day) | Cumulative Total (kg) |
Day 1 | 5 kg | 5 kg |
Day 5 | 5 kg | 10 kg |
Day 10 | 5 kg | 15 kg |
Day 15 | 5 kg | 20 kg |
Day 20 | 5 kg | 25 kg |
Day 25 | 5 kg | 30 kg |
*Total dosage required for full commissioning: Only 30 kg over 25 days.
4. Performance Results & Analytics
Key Metrics Achieved
85–90% COD Reduction: Inlet decreased from 7,187 mg/L to 874 mg/L across the UASBR alone.
VFA / Alkalinity Ratio: 0.18 (514.5 mg/L VFA to 2,821.5 mg/L Alkalinity). Optimal threshold is < 0.30.
Operational & Financial Benefits
Zero System Souring: Prevented costly organic overloads and secondary shock treatment expenses.
Rapid Commissioning: Achieved regulatory compliance in under 30 days without trial-and-error chemical additions.
Granular Sludge Formation: Port sample analytics confirmed healthy, dense granular sludge development with steady biogas conversion.
Traditional Seed Sludge vs BactaServe Anaerobic
Traditional Seed Sludge
❌ High risk of plant upset High microbial density
❌ Long startup (60–90 days)
❌ Low shock load tolerance
BactaServe Anaerobic
✔ High microbial density
✔ Commissioned in 25 days
✔ Formulated for APIs
Clear water separation was observed at digester ports 3, 4, and 5, showing healthy granular sludge formation and stable biogas production.
Ready to Optimize Your ETP Performance?
Get a customized dosing plan and technical consultation tailored to your plant's specific effluent parameters.
Step 1: Share your inlet COD, BOD, and flow parameters.
Step 2: Our bio-engineers analyze your process flow diagram.
Step 3: Receive a custom BactaServe dosing protocol with performance guidance.
Frequently Asked Questions
Q1: How do you reduce high COD in pharmaceutical wastewater using UASBR?
Answer: High Chemical Oxygen Demand (COD) in pharmaceutical wastewater is reduced in an Up-flow Anaerobic Sludge Blanket Reactor (UASBR) by adding specialized anaerobic microbial bio-cultures. BactaServe Anaerobic breaks down complex Active Pharmaceutical Ingredients (APIs) through four biological stages: hydrolysis, acidogenesis, acetogenesis, and methanogenesis. This process converts organic pollutants into biogas and can reduce inlet COD by up to 90%.
Q2: What is the optimal VFA to alkalinity ratio for a UASBR plant?
Answer: The ideal Volatile Fatty Acids (VFA) to alkalinity ratio for a stable UASBR system is between 0.10 and 0.30. Keeping the ratio close to 0.18 helps maintain good buffering capacity, prevents reactor souring, and supports efficient methane production during anaerobic digestion.
Q3: How long does it take to commission a pharmaceutical effluent treatment plant UASBR?
Answer: A traditional UASBR using unconditioned seed sludge usually takes 60 to 90 days to commission. With BactaServe Anaerobic, full biological commissioning and stable 85 to 90% COD reduction can be achieved in 25 to 30 days.
Q4: What is the recommended dosing protocol for BactaServe Anaerobic in a 30 KLD ETP?
Answer: For a 30 KLD pharmaceutical ETP, the recommended commissioning protocol is 30 kg of BactaServe Anaerobic over 25 days. Adding 5 kg every 5 days helps the bacteria adapt gradually, promotes granular sludge formation, and maintains a stable VFA to alkalinity ratio.
Q5: Can anaerobic bioculture treat wastewater from Cephalosporin API manufacturing?
Answer: Yes. BactaServe Anaerobic is a specialized anaerobic bioculture designed to treat wastewater containing Active Pharmaceutical Ingredients (APIs), including Cephalosporins such as Cefixime, Cefdinir, and Cefuroxime. It breaks down complex organic compounds that standard domestic sludge cannot effectively treat.
Q6: Why is granular sludge formation important in an anaerobic reactor?
Answer: Granular sludge formation is important in a UASBR because dense bacterial granules settle quickly and prevent bio-mass wash-out at high liquid up-flow velocities. Healthy, dark granular sludge shows a high concentration of active bacteria, faster organic matter breakdown, and stable biogas production.